Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Novartis CEO says shareholders ‘happy overall’ despite setbacks
CEO Vas Narasimhan told Fierce he believes most shareholders remain onside, while calling for adjustments to the U.S. Treasury's China plans.
James Waldron
,
Angus Liu
Nov 19, 2026 4:16am
Big Pharmas tell Fierce's London event about their ideal biotech
Nov 18, 2026 5:18am
Evaxion halts infectious disease work in R&D refocus on oncology
Nov 19, 2026 10:02am
nChroma halves headcount, halts trial of potential HBV ‘cure’
Nov 19, 2026 9:08am
Isomorphic adds Merck to drug discovery roster after $5B raise
Nov 19, 2026 8:47am
Teva loses R&D head amid push to grow innovative medicines unit
Nov 19, 2026 8:28am
More News
Fierce Biotech Fundraising Tracker '26: VitriVax, Ansa & more
Nov 19, 2026 5:00am
AbbVie busts a move with Disco in $2.5B bispecific dance
Nov 19, 2026 4:30am
Biogen’s tau drug drives bigger benefits in Alzheimer’s update
Nov 18, 2026 9:26am
Clene uses Veristat’s biostatistics platform for FDA submission
Nov 18, 2026 9:00am
See more stories